Use of AI as a Research Recruitment Tool: A DSMB Perspective.

The article focuses on the implications of using artificial intelligence (AI) for participant recruitment in clinical trials from the perspective of data safety monitoring boards (DSMBs), also known as data safety monitoring committees (DSMCs). It highlights the potential benefits of AI in enhancing...

Descripción completa

Detalles Bibliográficos
Publicado en:American Journal of Bioethics Vol. 26; no. 8; pp. 65 - 68
Autor principal: Barnbaum, Deborah R.
Formato: commentary Journal Article
Publicado: Taylor & Francis Ltd Aug2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=195895374&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 195895374
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15265161
        FKZ
      jtl: American Journal of Bioethics
      issn: 15265161
      maglogo: N
    pubinfo:
      dt: Aug2026
      vid: 26
      iid: 8
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        195895374
        195895374
        195895374
        10.1080/15265161.2026.2690925
        195895374
      ppf: 65
      ppct: 3
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Use of AI as a Research Recruitment Tool: A DSMB Perspective.
      aug:
        au: Barnbaum, Deborah R.
        affil: Kent State University
      sug:
        subj:
          Artificial Intelligence Utilization
          Research Ethics
          Research Subject Recruitment
          Clinical Trials
          Patient Selection
          Bioethics
          Safety
          Accountability
          Artificial Intelligence Ethical Issues
      ab: The article focuses on the implications of using artificial intelligence (AI) for participant recruitment in clinical trials from the perspective of data safety monitoring boards (DSMBs), also known as data safety monitoring committees (DSMCs). It highlights the potential benefits of AI in enhancing recruitment efficiency, reducing bias, and improving trial completion rates, which align with DSMB goals of protecting participants and ensuring scientific integrity. However, the article emphasizes challenges related to AI’s explainability, reliability, and oversight, recommending that researchers maintain transparency about AI use and that DSMBs incorporate AI expertise to properly evaluate recruitment algorithms. It also notes potential difficulties in expanding DSMB membership due to limited AI experts and varying opinions on adding specialized members, while underscoring the importance of early integration of such expertise to safeguard participant welfare.
      pubtype: Academic Journal
      doctype:
        commentary
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N